Concepedia

Author

J.-M. Nogaret

Institut Jules Bordet

Also Known As

J M Nogaret, J M. NOGARET, J Nogaret, J. M. Nogaret, J.-M Nogaret, J.-M. Nogaret, J.M Nogaret, J.M. Nogaret, Jean M. Nogaret, Jean Marie Nogaret

30

Publications

1K

Citations

9

H-Index

17

Concepts

All Affiliations

Institut Jules BordetUniversité Libre de Bruxelles
JN

About

J.-M. Nogaret is an author at Institut Jules Bordet specializing in radiation oncology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

159

2

Health Sciences

1

1

21

3

Obstetrics

1

1

64

4

Pathology

1

1

21

5

Radiation Medicine

1

1

21

J.-M. Nogaret

×

6

Publications

404

Citations

6

H-Index

YearCitations

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer

Martine Piccart, Angelo Di Leo, M. Beauduin,

Journal of Clinical Oncology

2001

163

Objective Regression of Unexcised Melanoma in-Transit Metastases After Hyperthermic Isolation Perfusion of the Limbs with Melphalan

Ferdy J. Lejeune, T. Deloof, Patricia Ewalenko,

Recent results in cancer research/Recent Results in Cancer Research

1983

74

Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring

M Vosse, Françoise Renard, Michel Coibion,

European Journal of Obstetrics & Gynecology and Reproductive Biology

2002

64

Immediate Breast Reconstruction with Implants and Adjuvant Chemotherapy: a Good Option ?

E. Vandeweyer, Rika Deraemaecker, J.-M. Nogaret,

Acta chirurgica Belgica

2003

53

Long-Term Benefit of High-Dose Epirubicin in Adjuvant Chemotherapy for Node-Positive Breast Cancer: 15-Year Efficacy Results of the Belgian Multicentre Study

Evandro de Azambuja, Marianne Paesmans, M. Beauduin,

Journal of Clinical Oncology

2008

29

How ‘hot’ is the pathologically positive sentinel lymph node in breast cancer patients?

Pierre Bourgeois, J.-M. Nogaret, Isabelle Veys,

Nuclear Medicine Communications

2003

21

Page 1